Women's Health Diagnostics Market Forecast 2024-2028

The global women's health diagnostics market size is estimated to grow by USD 14.60 billion at a CAGR of 8.09% between 2023 and 2028. The increasing prevalence of breast cancer, driven by various factors including lifestyle changes and aging populations, is driving market growth by increasing the demand for breast cancer screening, diagnosis, and treatment options. The increasing infertility rate in women, attributed to factors such as delayed childbearing and lifestyle factors, is also boosting market expansion by creating a demand for fertility treatments and services. Additionally, the increasing prevalence of sexually transmitted diseases (STDs), driven by changes in sexual behavior and inadequate access to healthcare, is driving the demand for STD testing, treatment, and prevention products. 

STDs are caused by the transmission of different bacteria, viruses, and parasites due to the exchange of vaginal fluids. There are more than 30 different bacteria, viruses, and parasites that can cause STDs. All through life, STDs have had a disproportionately negative impact on women. Syphilis, gonorrhea, chlamydia, hepatitis B, genital herpes, and HIV are among the several STDs. Major contributors to pelvic inflammatory illness and infertility in women are gonorrhea and chlamydia. The increasing incidences and prevalence of STDs are increasing the demand for screening and diagnosis of STDs at the earliest to reduce the chances of mortality. companies present across the globe are focusing on offering a wide range of STD-testing drugs.

What will be the size of the Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Segmentation 

By Application 

The market share growth by the breast cancer testing segment will be significant during the forecast period. A biopsy is the only reliable method for identifying breast cancer. The doctor performs a biopsy by using a specialized needle instrument to remove a core of tissue from the location while being guided by an X-ray or other imaging test.

Get a glance at the market contribution of various segments View a PDF Sample

The breast cancer testing segment was valued at USD 6.55 billion in 2018. Biopsy samples are analyzed in a laboratory to determine whether or not they contain cancer cells. The type of cells involved in breast cancer, its aggressiveness (grade), and whether the cancer cells have hormone receptors or other receptors that could affect treatment options are all determined by analyzing a biopsy sample.

By End-user 

Over the years, hospitals and clinics have developed advanced medical infrastructure to cater to the needs of people. One of the major focus areas in hospitals is to increase the screening, monitoring, and diagnosis of various chronic diseases, such as cervical cancer and breast cancer in outpatient settings. For women who do not have other sources of screening, the opportunity to perform diagnostic tests in a hospital or clinical setting is available. An accurate test for cancer, such as a biopsy test, during hospital admission, plays a vital role in reducing the mortality rates of breast and cervical cancer. With an increase in the number of hospitals and clinics and the increased convenience provided by them, they are expanding women's health diagnostic services related to infertility, gynecology, menopause, and others, which have provided patients with a broader range of treatment options to choose from based on cost and effectiveness. Also, with an increase in the number of hospitals and clinics, there is easier access to women's health diagnostic services.

Diagnostic and imaging centers

Due to the increasing prevalence of chronic and infectious diseases and associated risk factors among women, the rapidly growing elderly women population, and the increasing number of women health studies and surgical imaging procedures, the diagnostic and imaging center segment is expected to grow steadily during the forecast period. Diagnostic imaging, which supports the diagnosis and treatment of diseases, has rapidly evolved into a vital role in modern medicine. In addition, diagnostics and imaging equipment have been constantly developed by companies operating on the market. With the rising number of chronic diseases among women and investment in the healthcare sector, diagnostic and imaging centers will witness growth, which, in turn, is expected to propel the growth of the global market during the forecast period.

By Region

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America has been witnessing an increase in the adoption of various advanced diagnostic technologies over the past few years. In this region, the majority of market growth is due to technological adoption, increasing health care expenditure, rising prevalence of diseases like cancer, and increased levels of awareness about breast cancer screening and diagnosis. This is one of the most common chronic diseases found in people in this region. According to the CDC, breast cancer is one of the most common types of cancer in women, and it is the second leading cause of cancer deaths among women in the US.

Buy Now Full Report and Discover More

Key Women Health Diagnostics Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Abbott Laboratories, Becton Dickinson and Co. - The company offers women's health diagnostics such as menstrual medicine called Duphaston and Iberet Folic 500.

• Bio Rad Laboratories Inc.
• Danaher Corp.
• Exact Sciences Corp.
• F. Hoffmann La Roche Ltd.
• FUJIFILM Corp.
• GE Healthcare Technologies Inc.
• Hologic Inc.
• Illumina Inc.
• Invitae Corp.
• Myriad Genetics Inc.
• Natera Inc.
• PerkinElmer Inc.
• QIAGEN NV
• Quest Diagnostics Inc.
• Quidelortho Corp.
• Siemens AG
• Thermo Fisher Scientific Inc.
• and Koninklijke Philips N.V.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics and Customer Landscape

The market encompasses a range of diagnostic methods tailored to address specific health concerns like ovarian cancer, pregnancy, and chronic conditions prevalent among the geriatric female population. Medical diagnostics devices, including biopsy devices and imaging and monitoring systems, play a crucial role in early detection and treatment monitoring of diseases such as breast cancer and osteoporosis. Point of care diagnostic testing is gaining prominence in managing chronic and lifestyle disorders like AIDS and urinary tract infections, enhancing medical science's capabilities. Imaging techniques offered by institutions like the National Centre of Health Sciences facilitate accurate diagnosis and treatment planning. The market's growth is fueled by advancements in medical technology and increasing awareness, ensuring comprehensive healthcare solutions for women worldwide.

Key Market Drivers

The increasing prevalence of breast cancer is driving growth in the women's health diagnostics market. Cancer is a widespread chronic disease that is increasingly becoming a significant health concern, contributing to the rising global mortality rates. Among the various types of cancer, breast cancer stands out as one of the most common forms affecting women. The growing prevalence of breast cancer is closely linked to the expanding elderly population, as it is more commonly diagnosed in older women worldwide.

This trend underscores the importance of regular screening and early detection methods such as digital and mobile mammography, breast MRI, ultrasound, and bone density testing, especially for women-centric conditions. To combat the impact of breast cancer, regular screening is essential for women globally to detect any signs or symptoms early and reduce mortality rates. The demand for screening has surged worldwide due to the escalating death rates associated with the disease. Healthcare professionals recommend and conduct diagnostic procedures such as X-rays or MRIs to detect breast cancer in patients, which is expected to drive market growth in the forecast period.

Significant Market Trends

The adoption of advanced diagnostic solutions is a primary trend in the market. Breast cancer management and infectious disease testing using immunoassay and molecular diagnostic technologies are becoming more and more common. The availability of advanced treatment care also enables increased adoption rates among healthcare providers. The growth of specialist tests in esoteric, pathology, and genetic areas will continue to grow over the forecast period even though currently there is more activity associated with normal diagnostics. The increased need for diagnostic products encourages companies to focus on providing customized automation solutions to address the needs of patients. 

Moreover, the adoption of point-of-care testing (POCT) is rising globally due to its efficient workflow process and advantages such as the ability to be performed at the bedside, portability, and timely and rapid diagnosis. Thus, the increasing adoption of advanced diagnostics solutions will propel the growth of the market focus during the forecast period.

Major Market Challenges

The lack of trained laboratory technicians is a major challenge in the market challenge.  Trained professionals with better dexterity skills, able to handle tools and perfectly perform procedures, are required for almost all of the critical diagnostics tests like immunoassays and molecular diagnosis. The need for expensive and multi-year theoretical studies to become qualified professionals or technicians also contributes to the shortage of trained laboratory technicians. An important role in the early detection and treatment of diseases is to be played by expertise and skills in handling and use of diagnostic tools.

Moreover, the market has a shortage of trained professionals who can handle technologically advanced diagnostic devices. The results of tests may be affected due to errors in data input, which can have an impact on diagnosis using automatic handling systems. The lack of expertise is likely to lead to an incorrect diagnosis. Trained professionals must handle automated handling systems, as accuracy and reliability play a vital role in laboratories. Hence, the limited number of trained staff will negatively affect market growth during the forecast period.

Buy Now Full Report and Discover More

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Market Customer Landscape

Segment Overview

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion " for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• Application Outlook 
  • Breast cancer testing
  • Infectious disease testing
  • STD testing
  • Cervical cancer testing
  • Others

• End-user Outlook 
  • Hospitals and clinics
  • Diagnostic and imaging centers
  • Home care settings

• Region Outlook 
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • ROW
    • Argentina
    • Australia
    • Brazil

You may also interested in below market reports

• Femtech Market: Analysis North America, Europe, Asia, Rest of World (ROW) - US, UK, Israel, India, Canada - Size and Forecast 

• Breast Imaging Technologies Market: Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, Japan, China - Size and Forecast 

• Immunodiagnostics Market: Analysis North America, Europe, Asia, Rest of World (ROW) - US, UK, Germany, Canada, China - Size and Forecast

Market Analyst Overview

The market is advancing rapidly with a focus on various types of tests including prenatal genetic screening, ovarian cancer testing, and breast cancer diagnosis. Key technologies such as biopsy devices, imaging and monitoring systems like ultrasound and mammography systems, are pivotal in early detection and treatment planning. Diagnostic centers, supported by skilled professionals, cater to infectious diseases segments such as SARS, H1N1, Ebola, and Mycobacterium TB, enhancing healthcare outcomes globally. Regional opportunities in emerging countries drive healthcare expenditure towards improved diagnostic and imaging centers, integrating accessories and consumables for comprehensive patient care. The market embraces latest trends in genomic testing and prenatal segments like hepatitis B virus testing, while homecare segments address needs such as yeast infections and colon cancer monitoring, ensuring holistic healthcare solutions for women's health.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting of the market between 2024 and 2028
• Precise estimation of the size of the market size and its contribution to the parent market
• Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
• Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
• Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch